Ying Zhang

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 02, 2024
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter study.

Ying Zhang, Kazushi Numata, Kento Imajo

Pageof 1

Frequent Collaborators

1 joint publications

Hisashi Hidaka

1 joint publications

Tatehiro Kagawa